Company Overview and News

 
Top Analyst Upgrades and Downgrades: Amazon, Caterpillar, Exxon, Honeywell, Lululemon, Merck, Petrobras, Under Armour and More

2h 247wallst
Stocks were indicated to open marginally higher on Monday morning, but not enough so that the trends look set in stone. Some investors have reconsidered what the nine-year bull market may bring in 2018 and beyond. It has become much more clear that the trend of buying pullbacks is now more vulnerable to sellers, volatility and each major news headline. Many investors are finding it hard to decide how they want their assets positioned for the longer term.
Upvote Downvote

 
Bespoke's Most Volatile Stocks On Earnings: April 2018 Edition

2018-04-10 seekingalpha
The first-quarter earnings season began Monday. With the stock market struggling lately, there seem to be a lot of bulls hanging their hopes on earnings strength to help pull the market out of correction territory.
Upvote Downvote

 
The Zacks Analyst Blog Highlights: Paycom, Burlington and United States Cellular

2018-04-09 zacks
Chicago, IL – April 9, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Paycom Software, Inc. (PAYC - Free Report) , Burlington Stores, Inc. (BURL - Free Report) and United States Cellular Corporation (USM - Free Report) .
Upvote Downvote

 
The Zacks Analyst Blog Highlights: Alphabet, Chevron, Raytheon, Chubb and T. Rowe

2018-04-09 zacks
Chicago, IL – April 9, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Alphabet (GOOGL - Free Report) , Chevron (CVX - Free Report) , Raytheon (RTN - Free Report) , Chubb (CB - Free Report) and T. Rowe Price (TROW - Free Report) .
Upvote Downvote

 
Zacks.com featured highlights include: Abaxis, Haynes International, MakeMyTrip and Vectrus

2018-04-09 zacks
Chicago, IL – April 9, 2018 - Stocks in this week’s article Abaxis, Inc. (ABAX - Free Report) , Haynes International, Inc. (HAYN - Free Report) , MakeMyTrip Limited (MMYT - Free Report) and Vectrus, Inc. (VEC - Free Report) .
Upvote Downvote

 
Zacks Industry Outlook Highlights: Norfolk Southern, CSX, Kansas City, Genesee & Wyoming and Union Pacific

2018-04-09 zacks
Chicago, IL – April 9, 2018 – Today, Zacks Equity Research discusses the Industrial Metals, including Norfolk Southern Corp. (NSC - Free Report) , CSX Corp. (CSX - Free Report) , Kansas City Southern (KSU - Free Report) , Genesee & Wyoming, Inc. (GWR - Free Report) and Union Pacific Corp. (UNP - Free Report) .
Upvote Downvote

 
The Zacks Analyst Blog Highlights: Archer Daniels, Tyson Foods, Hormel, Campbell and Brown-Forman

2018-04-09 zacks
Chicago, IL – April 9, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Archer Daniels Midland Company (ADM - Free Report) , Tyson Foods, Inc. (TSN - Free Report) , Hormel Foods Corporation (HRL - Free Report) , Campbell Soup Company (CPB - Free Report) and Brown-Forman Corporation (BF.
Upvote Downvote

 
The Zacks Analyst Blog Highlights: KB Home, Beazer, Lyon William and M.D.C.

2018-04-09 zacks
Chicago, IL – April 9, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include KB Home (KBH - Free Report) , Beazer Homes USA, Inc. (BZH - Free Report) , Lyon William Homes (WLH - Free Report) and M.D.C. Holdings, Inc.
Upvote Downvote

 
The Zacks Analyst Blog Highlights: Shenandoah, AES, Global Water, CenterPoint and ONEOK

2018-04-09 zacks
Chicago, IL – April 9, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Shenandoah Telecommunications Company (SHEN - Free Report) , The AES Corporation (AES - Free Report) , Global Water Resources, Inc. (GWRS - Free Report) , CenterPoint Energy, Inc.
Upvote Downvote

3
Game Plan For The Week - Cramer's Mad Money (4/6/18)

2018-04-09 seekingalpha
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Friday, April 6.
Upvote Downvote

 
Zacks.com highlights: Live Nation Entertainment, PTC, AMC Entertainment Holdings, Mattel and Covanta Holding

2018-04-06 zacks
Chicago, IL – April 6, 2018 - Stocks in this week’s article include: Live Nation Entertainment, Inc. (LYV - Free Report) , PTC Inc. (PTC - Free Report) , AMC Entertainment Holdings, Inc. (AMC - Free Report) , Mattel, Inc. (MAT - Free Report) and Covanta Holding Corporation (CVA - Free Report) .
Upvote Downvote

 
Zacks Value Investor Highlights: AdvanSix, El Pollo Loco, Caleres, SPDR S&P 600 and Vanguard Small Cap Value

2018-04-06 zacks
Chicago, IL – April 6, 2018 – Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: (https://www.zacks.com/stock/news/298047/how-small-investments-can-add-up-to-big-bucks)
Upvote Downvote

 
Ralph Lauren (RL) Poised for Growth: Surges 44% in a Year

2018-04-06 zacks
Ralph Lauren Corp. (RL - Free Report) has been a solid investment pick for quite a while now as it continues to portray a strong earnings trend, backed by smooth progress on the Way Forward Plan alongside strategic efforts to expand digital and international presence. The cumulative effect of these efforts is clearly visible in its price performance graph, which continues to scale up despite all odds.
Upvote Downvote

 
Zacks.com highlights: Verso, DMC Global, QuinStreet and Arcos Dorados Holdings

2018-04-06 zacks
Chicago, IL – April 6, 2018 - Stocks in this week’s article include: Verso Corp. (VRS - Free Report) , DMC Global Inc. (BOOM - Free Report) , QuinStreet, Inc. (QNST - Free Report) and Arcos Dorados Holdings Inc. (ARCO - Free Report) .
Upvote Downvote

 
Zacks.com highlights: Michael Kors Holdings, Ligand Pharmaceuticals, Tivity Health, NV5 Global and Louisiana-Pacific

2018-04-06 zacks
Chicago, IL – April 6, 2018 - Stocks in this week’s article include: Michael Kors Holdings Ltd. (KORS - Free Report) , Ligand Pharmaceuticals Inc. (LGND - Free Report) , Tivity Health, Inc. (TVTY - Free Report) , NV5 Global, Inc. (NVEE - Free Report) and Louisiana-Pacific Corp. (LPX - Free Report) .
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: G60754101